ReviewCurrent atherosclerosis reports2026
Alignment of Food Policies and Cardiovascular Disease Burden: Insights from the Literature.
Review in Current atherosclerosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis narrative review aims to synthesize global literature on existing food policies relevant to cardiovascular disease (CVD) prevention and assess their alignment with global CVD burden. RECENT
findingsMandatory food reformulation policies, particularly industrial trans-fat elimination and sodium reduction targets, demonstrate the strongest and most consistent impacts on population dietary risk factors and cardiovascular outcomes. Fiscal measures, notably sugar-sweetened beverage taxes, are associated with reduced purchases, product reformulation, and potential cardiometabolic benefits, though implementation remains uneven. Marketing restrictions-largely focused on children-and front-of-pack labelling can reduce exposure to unhealthy foods and improve nutritional visibility, but their effectiveness varies by regulatory strength, enforcement, and context. Across all policy domains, adoption and evaluation remain limited in low-and middle-income countries (LMICs). Despite strong evidence supporting food policies as effective tools for CVD prevention, substantial gaps persist in coverage, enforcement, and alignment with global disease burden. Regions with rapidly rising CVD rates continue to lack comprehensive, mandatory policies. Integrated policy packages combining reformulation, fiscal measures, marketing regulation, and labelling are likely required to achieve equitable and sustained reductions in cardiovascular risk.
Indexed as
Identifiers
42663764What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.